CorMedix CRMD Income Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $38.6M+87.0% | $14.02M— | $108.56M+4,010% | $19.83M+240% | $20.64M+243% | ||
| $74.2M+266% | $69.56M— | $55.11M+1,817% | $19.71M+229% | $20.29M+222% | ||
| $63.66M+216% | $59.13M— | $51.35M+1,662% | $19.54M+228% | $20.13M+220% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is CorMedix's revenue?
- CorMedix (CRMD) generated $400.1M in revenue over the trailing twelve months, up 384.6% year over year.
- Is CorMedix profitable?
- CorMedix reported $181.0M in net income over the trailing twelve months, a 45.2% net margin.
- What are CorMedix's profit margins?
- Gross margin is 91.9% and operating margin is 48.4%, with a 45.2% net margin.
- What is CorMedix's earnings per share?
- CorMedix's diluted EPS over the trailing twelve months is $2.04.
- Where does CorMedix's income statement data come from?
- Every line is extracted from CorMedix's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
